Company powering cardiac therapeutics from a mobile phone using proprietary AI-based ECG analysis and software to expand access to remote patient monitoring, remote therapeutic monitoring, and cardiac implantable electronic device monitoring.
Company powering cardiac therapeutics from a mobile phone using proprietary AI-based ECG analysis and software to expand access to remote patient monitoring, remote therapeutic monitoring, and cardiac implantable electronic device monitoring.
Software platform for ECG analysis and cardiac care, designed for clinicians to quickly assess patient information from a mobile phone using explainable AI and custom tools that...
What customers say
“SafeBeat has the potential to dramatically improve care of patients who require in-patient monitoring for drug initiation, and may thus improve patient care and workflows.”
CustomerSafeBeat Rx customer
“Heart Rhythm Society plays a key role in supporting new technologies like yours, which respond to the needs of both patients and healthcare systems and help advance our specialty.”
CustomerSafeBeat Rx customer
Security and compliance
As reported by SafeBeat Rx. Ask for audit reports before you buy.
Do Not Track signal support
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
SafeBeat Rx Appoints Walker McHugh as Strategic Advisor
Walker McHugh has been appointed as a Strategic Advisor for SafeBeat Rx. Mr. McHugh brings over seven years of experience in diagnostics and healthcare commercialization. He previously served as the Founder and CEO of Refractal, a healthcare technology startup that achieved FDA Breakthrough Device designation, and most recently held the position of Director of Clinical Operations at Curebase.
